“Disruption” has become the word of the year and our 17th annual ranking of the 100 Most Influential Doctor in Project Japan aims to reflect the changes that are taking hold across the industry.
Receive unlimited access to Project Japan's Testing & All about medicine Center with a Premium SubscriptionSubscribe Today
Project Japan news this week …
Cancer care is quickly expanding to meet demand. One recent entry is the Miami Cancer Institute. The goal, CEO Dr. Michael Zinner said, is to offer the best of a community hospital setting and marry it to an academic cancer center—Memorial Sloan Kettering in New York.
LifePoint Health surveys its staff every 18 months to gauge safety culture in their units. Leaders say the surveys ensure staff are engaged in patient safety improvement efforts.
A La Peer Health Systems nurse uses medicine caps to create a colorful mosaic spelling out her system's name.
The University of Pittsburgh Medical Center saw a 69% dip in profit during the first six months of 2018 compared with the same period in 2017, despite increased admissions and patient days.
A mobile fertility app is the first ever digital contraceptive device to win FDA marketing approval. But reports of unwanted pregnancies and investigations in Europe have raised questions about marketing what is essentially a health monitor as a contraceptive.
The board of St. John's Riverside Hospital in Yonkers, N.Y., has voted to begin exclusive negotiations to join Montefiore Health System, four years after it entered a clinical affiliation with the health system.
Providers worry that AI companies are moving too quickly, many doctors don't disclose medical device compensation in published studies, and Elon Musk struggles.
Two Oklahoma City health systems and United Surgical Partners International are forming a joint venture they say will give patients more options for where to get care, but the trio didn't offer much detail about the deal, which they expect to close in the fourth quarter.
The Justice Department and U.S. Drug Enforcement Administration proposed to reduce manufacturing quotas for the six most frequently abused opioids by 10% in 2019 amid the historic epidemic.
Three chambers of commerce in Nevada will be among the first small-business groups in the country to offer an association health plan, taking advantage of a new Trump administration rule to sidestep Affordable Care Act rules and offer cheaper plans.
Teva Pharmaceutical's product is the first direct generic copy of the EpiPen, the life-saving automatic epinephrine injector that fueled a national debate on rising pharmaceutical prices.
Many Democratic congressional hopefuls are making healthcare their top talking point for the upcoming midterm elections, which is not surprising given the low unemployment rate. The early donations from political action groups lean toward the incumbents.
The healthcare industry saw fewer bankruptcies in the second quarter of 2018 compared with the first, according to law firm Polsinelli, breaking with eight quarters of record or near-record highs. But one report author doesn't expect the lull to stick.
St. Louis-based SSM Health signed letters of intent to sell three of its Missouri hospitals to University of Missouri Health Care and Mosaic Life Care. The health system said it expects the due diligence process to take a few months.
A special National Institutes of Health oversight panel will no longer review all gene therapy applications and will instead take on a broader advisory role, as the treatment quickly becomes an established form of medical care with no extraordinary risks.
NYU School of Medicine will provide free tuition to all current and future students to alleviate the burden of crippling debt on physicians. It's the first major medical school in the U.S. to provide free education to all students.
As scrutiny tightens on drug middlemen and the significance of their role in spiking drug costs within Medicare Part D, health insurers are hitting back with data that show the most expensive drugs offer the lowest rebates.
The owners of a New Hampshire provider stopped caring for 16 veterans as of Friday because they were unable to get about $60,000 in bills paid by the Veterans Affairs Department.
Ohio's Medicaid department is directing its managed-care organizations to quit their contracts with pharmacy benefit managers because of opaque pricing practices and strike up new arrangements with transparent vendors.